Thomas Nestelberger1,2, Jasper Boeddinghaus1,2,3, Jaimi Greenslade4,5,6, William A Parsonage4,5,6, Martin Than7, Desiree Wussler1,2,3, Pedro Lopez-Ayala1,2, Tobias Zimmermann1,2, Mario Meier1,2, Valentina Troester1,2, Patrick Badertscher1,2,8, Luca Koechlin1,2,9, Karin Wildi1,3,10, Mahnoor Anwar1,2, Michael Freese1,2, Dagmar I Keller11, Tobias Reichlin1,2,12, Raphael Twerenbold1,2, Louise Cullen2,4,5,6, Christian Mueller13,2. 1. Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland. 2. GREAT network. 3. Division of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland. 4. Royal Brisbane and Women's Hospital, Brisbane, Australia. 5. Queensland University of Technology, Brisbane, Australia. 6. University of Queensland, Brisbane, Australia. 7. Emergency Department, Christchurch Hospital, Christchurch, New Zealand. 8. Division of Cardiology, University of Illinois at Chicago, Chicago, IL. 9. Department of Cardiac Surgery, University Hospital Basel, University of Basel, Basel, Switzerland. 10. Critical Care Research Institute, The Prince Charles Hospital, Brisbane and University of Queensland, Brisbane, Australia. 11. Emergency Department, University Hospital Zurich, Zurich, Switzerland. 12. Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. 13. Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; christian.mueller@usb.ch.
Abstract
BACKGROUND: We aimed to derive and externally validate a 0/2-h algorithm using the high-sensitivity cardiac troponin I (hs-cTnI)-Access assay. METHODS: We enrolled patients presenting to the emergency department with symptoms suggestive of acute myocardial infarction (AMI) in 2 prospective diagnostic studies using central adjudication. Two independent cardiologists adjudicated the final diagnosis, including all available medical information including cardiac imaging. hs-cTnI-Access concentrations were measured at presentation and after 2 h in a blinded fashion. RESULTS: AMI was the adjudicated final diagnosis in 164 of 1131 (14.5%) patients in the derivation cohort. Rule-out by the hs-cTnI-Access 0/2-h algorithm was defined as 0-h hs-cTnI-Access concentration <4 ng/L in patients with an onset of chest pain >3 h (direct rule-out) or a 0-h hs-cTnI-Access concentration <5 ng/L and an absolute change within 2 h <5 ng/L in all other patients. Derived thresholds for rule-in were a 0-h hs-cTnI-Access concentration ≥50 ng/L (direct rule-in) or an absolute change within 2 h ≥20 ng/L. In the derivation cohort, these cutoffs ruled out 55% of patients with a negative predictive value (NPV) of 99.8% (95% CI, 99.3-100) and sensitivity of 99.4% (95% CI, 96.5-99.9), and ruled in 30% of patients with a positive predictive value (PPV) of 73% (95% CI, 66.1-79). In the validation cohort, AMI was the adjudicated final diagnosis in 88 of 1280 (6.9%) patients. These cutoffs ruled out 77.9% of patients with an NPV of 99.8% (95% CI, 99.3-100) and sensitivity of 97.7% (95% CI, 92.0-99.7), and ruled in 5.8% of patients with a PPV of 77% (95% CI, 65.8-86) in the validation cohort. CONCLUSIONS: Safety and efficacy of the l hs-cTnI-Access 0/2-h algorithm for triage toward rule-out or rule-in of AMI are very high. TRIAL REGISTRATION: APACE, NCT00470587; ADAPT, ACTRN1261100106994; IMPACT, ACTRN12611000206921.
BACKGROUND: We aimed to derive and externally validate a 0/2-h algorithm using the high-sensitivity cardiac troponin I (hs-cTnI)-Access assay. METHODS: We enrolled patients presenting to the emergency department with symptoms suggestive of acute myocardial infarction (AMI) in 2 prospective diagnostic studies using central adjudication. Two independent cardiologists adjudicated the final diagnosis, including all available medical information including cardiac imaging. hs-cTnI-Access concentrations were measured at presentation and after 2 h in a blinded fashion. RESULTS:AMI was the adjudicated final diagnosis in 164 of 1131 (14.5%) patients in the derivation cohort. Rule-out by the hs-cTnI-Access 0/2-h algorithm was defined as 0-h hs-cTnI-Access concentration <4 ng/L in patients with an onset of chest pain >3 h (direct rule-out) or a 0-h hs-cTnI-Access concentration <5 ng/L and an absolute change within 2 h <5 ng/L in all other patients. Derived thresholds for rule-in were a 0-h hs-cTnI-Access concentration ≥50 ng/L (direct rule-in) or an absolute change within 2 h ≥20 ng/L. In the derivation cohort, these cutoffs ruled out 55% of patients with a negative predictive value (NPV) of 99.8% (95% CI, 99.3-100) and sensitivity of 99.4% (95% CI, 96.5-99.9), and ruled in 30% of patients with a positive predictive value (PPV) of 73% (95% CI, 66.1-79). In the validation cohort, AMI was the adjudicated final diagnosis in 88 of 1280 (6.9%) patients. These cutoffs ruled out 77.9% of patients with an NPV of 99.8% (95% CI, 99.3-100) and sensitivity of 97.7% (95% CI, 92.0-99.7), and ruled in 5.8% of patients with a PPV of 77% (95% CI, 65.8-86) in the validation cohort. CONCLUSIONS: Safety and efficacy of the l hs-cTnI-Access 0/2-h algorithm for triage toward rule-out or rule-in of AMI are very high. TRIAL REGISTRATION: APACE, NCT00470587; ADAPT, ACTRN1261100106994; IMPACT, ACTRN12611000206921.
Authors: Tania Coscia; Thomas Nestelberger; Jasper Boeddinghaus; Pedro Lopez-Ayala; Luca Koechlin; Òscar Miró; Dagmar I Keller; Ivo Strebel; Ana Yufera Sanchez; Bernhard Okamura; Desiree Wussler; Samyut Shrestha; Katharina Hausknecht; F Javier Martín-Sánchez; Michael Christ; Damian Kawecki; Raphael Twerenbold; Karin Wildi; Maria Rubini Gimenez; Christian Mueller Journal: JAMA Cardiol Date: 2022-04-01 Impact factor: 30.154
Authors: Júlia Karády; Thomas Mayrhofer; Maros Ferencik; John T Nagurney; James E Udelson; Andreas A Kammerlander; Jerome L Fleg; W Frank Peacock; James L Januzzi; Wolfgang Koenig; Udo Hoffmann Journal: J Am Coll Cardiol Date: 2021-03-30 Impact factor: 24.094
Authors: W Frank Peacock; Robert Christenson; Deborah B Diercks; Christian Fromm; Gary F Headden; Christopher J Hogan; Erik B Kulstad; Frank LoVecchio; Richard M Nowak; Jon W Schrock; Adam J Singer; Alan B Storrow; Joely Straseski; Alan H B Wu; Daniel P Zelinski Journal: Acad Emerg Med Date: 2020-03-27 Impact factor: 3.451
Authors: Evangelos Giannitsis; Stefan Blankenberg; Robert H Christenson; Norbert Frey; Stephan von Haehling; Christian W Hamm; Kenji Inoue; Hugo A Katus; Chien-Chang Lee; James McCord; Martin Möckel; Jack Tan Wei Chieh; Marco Tubaro; Kai C Wollert; Kurt Huber Journal: Clin Res Cardiol Date: 2021-02-26 Impact factor: 5.460